Multimodal phenotyping In patients Referred with Acute Cardiac faiLurE

Multimodal phenotyping In patients Referred with Acute Cardiac faiLurE - MIRACLE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031931

Enrollment

1000

Registered

2025-03-10

Start date

2024-08-07

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R57.0

Interventions

Group 1: This observational study assesses clinical treatment characteristics, including ECG, echocardiography, hemodynamic evaluations, laboratory tests, and additional biobanking (blood and urine).

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Cardiogenic shock SCAI B-E

Exclusion criteria

Exclusion criteria: Post-cardiotomy cardiogenic shock Unable to consent due to reasons outside cardiogenic shock

Design outcomes

Primary

Measure	Time frame
30 day mortality	—

Secondary

Measure	Time frame
Exploratory secondary endpoints include the association of circulating biomarkers, imaging and functional data with clinical endpoints such as hospital mortality and re-hospitalization for heart failure. Furthermore, long-term outcomes after cardiogenic shock will be investigated (clinical endpoints and patient reported outcomes).	—

Countries

Germany

Contacts

Public ContactLucas Bacmeister

Universitäts-Herzzentrum Freiburg - Bad Krozingen

lucas.bacmeister@uniklinik-freiburg.de+4976127035603

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026